Lymphedema clinical trials
27 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Pedal Pump and Leg Lymphedema
- A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
- Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema
- Evaluation of Combination Therapy for Upper Extremity Lymphedema
- Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema
- LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
- Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
- Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
- Screening For BCRL In Targeted Therapy For Breast Cancer
- Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy or Pelvic Lymphadenectomy: A Prospective Observational Study
- Prospective Assessments Following Immediate Lymphatic Reconstruction
- A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
- Objective Assessment of Outcomes Following Immediate Lymphatic Reconstruction / LYMPHA
- A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management
- A Prospective Natural History Study of Lymphatic Anomalies
- Vascular Lab Resource (VLR) Biorepository
- A Real-World Registry of Chronic Wounds and Ulcers
- LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
- Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
- Evaluating Factors In Study Experiences of Lymphedema Patients
- Advancing Patient Care for Lymphatic Pain and Lymphedema
- Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Postoperative Pain After Mastectomy
- Assessing Impact of Early Physiotherapy on Lymphatic Dysfunction in Head and Neck Cancer Survivorship
- Biorepository of Biomarkers for Optimization of Microvascular Treatment of Lymphedema
- Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
- Sub-Hertz Analysis of Viscoelasticity of Limbs in Patients With Lymphedema
- Comparing Two Ways to Manage Head and Neck Lymphedema
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Lymphedema” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.